Continued Access Study for Patients Benefiting from Avelumab in Closing Pfizer-Sponsored Studies
Sponsor: Pfizer
ClinicalTrials ID:NCT05059522
This study allows patients who are benefiting from Avelumab in certain Pfizer-sponsored studies that are ending to continue receiving treatment and be monitored for safety and survival.
Patient Parameters
| Parameter | Options |
|---|
Program Overview
This study is designed to provide ongoing access to Avelumab treatment for patients who are currently benefiting from it in Pfizer-sponsored studies that are closing. It ensures that these patients can continue their treatment and receive follow-up care to monitor their safety and overall survival.
Description
This study, identified as B9991046, includes several sub-studies from previous Pfizer-sponsored research involving Avelumab. These sub-studies are from the following parent studies: B9991001, B9991003, B9991004, B9991005, B9991009, B9991023, B9991025, B9991027, and B9991032. The goal is to allow patients who are experiencing positive effects from Avelumab to keep receiving the medication and to track their health outcomes.
Eligibility Criteria
Inclusion Criteria
- Patients who are currently receiving Avelumab and experiencing significant benefits from it, or who are in the follow-up phase for safety or survival in a Pfizer-sponsored study.
- Patients must agree to follow specific guidelines regarding reproduction.
- Patients must be willing and able to attend all scheduled visits and follow the treatment plan and study procedures.
Exclusion Criteria
- Women who are pregnant or breastfeeding cannot participate.
- Any medical condition that the study doctor or sponsor believes would make it unsafe for the patient to participate.
Locations
| FACILITY | ZIP | CITY | STATE |
|---|---|---|---|
| Highlands Oncology Group, PA | 72703 | Fayetteville | Arkansas |
| Highlands Oncology Group, PA | 72758 | Rogers | Arkansas |
| Highlands Oncology Group, PA | 72762 | Springdale | Arkansas |
| UCLA Hematology/Oncology | 90095 | Los Angeles | California |
| Moffitt Cancer Center | 33612 | Tampa | Florida |
| MSK Basking Ridge | 07920 | Basking Ridge | New Jersey |
| MSK Monmouth | 07748 | Middletown | New Jersey |
| MSK Bergen | 07645 | Montvale | New Jersey |
| MSK Commack | 11725 | Commack | New York |
| MSK Westchester | 10604 | Harrison | New York |
Get This Program In Your Inbox
Receive detailed information about this treatment opportunity to review with your healthcare provider.